Screening strategies for hip dysplasia: long-term outcome of a randomized controlled trial

Lene B Laborie1, Ingvild Ø Engesæter, Trude G Lehmann

  • 1Department of Clinical Medicine, University of Bergen, Norway. lene.bjerke.laborie@helse-bergen.no

Pediatrics
|August 21, 2013
PubMed

Insights

Ultrasound screening for hip dysplasia in newborns did not show significant long-term benefits in radiographic markers of dysplasia or degenerative changes at skeletal maturity. Despite reduced late cases, increased treatment rates were not linked to avascular necrosis (AVN).

Area of Science:

  • Orthopedics
  • Radiology
  • Pediatric Health

Background:

  • Screening for hip dysplasia remains controversial.
  • Previous trials showed nonsignificant reductions in late cases with ultrasound screening but increased treatment rates.
  • This study evaluates long-term outcomes of different newborn screening strategies.

Purpose of the Study:

  • To assess radiographic markers of acetabular dysplasia and degenerative changes at skeletal maturity.
  • To evaluate the incidence of avascular necrosis (AVN) secondary to neonatal treatment.
  • To compare outcomes between universal ultrasound, selective ultrasound, and clinical examination screening strategies.

Main Methods:

  • A cohort of 3935 adolescents (aged 18-20) from an initial trial of 11,925 newborns were followed up.
  • Standardized weight-bearing anteroposterior hip X-rays were obtained.
  • Radiographic outcomes included measures of dysplasia and joint-space width; AVN signs were documented.

Main Results:

  • 2011 adolescents (58.2% female) were included in the final analysis.
  • No statistically significant differences in radiographic findings of dysplasia or degenerative changes were detected between the universal ultrasound, selective ultrasound, and clinical examination groups.
  • No cases of avascular necrosis (AVN) were observed.

Conclusions:

  • Ultrasound screening (universal or selective) did not demonstrate a significant reduction in radiographic markers of hip dysplasia or degenerative changes at skeletal maturity compared to clinical examination alone.
  • While ultrasound screening showed a trend towards reducing late-presenting cases, this did not translate to improved long-term radiographic outcomes.
  • Increased treatment rates associated with ultrasound screening were not linked to adverse events like AVN.
Abstract

Related Concept Videos